381 related articles for article (PubMed ID: 15542773)
1. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides.
Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE
Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773
[TBL] [Abstract][Full Text] [Related]
2. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
Shangary S; Johnson DE
Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
[TBL] [Abstract][Full Text] [Related]
3. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
Moreau C; Cartron PF; Hunt A; Meflah K; Green DR; Evan G; Vallette FM; Juin P
J Biol Chem; 2003 May; 278(21):19426-35. PubMed ID: 12642586
[TBL] [Abstract][Full Text] [Related]
4. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL.
Yamaguchi H; Wang HG
J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137
[TBL] [Abstract][Full Text] [Related]
5. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.
Kuwana T; Bouchier-Hayes L; Chipuk JE; Bonzon C; Sullivan BA; Green DR; Newmeyer DD
Mol Cell; 2005 Feb; 17(4):525-35. PubMed ID: 15721256
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
[TBL] [Abstract][Full Text] [Related]
7. Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells.
Li R; Boehm AL; Miranda MB; Shangary S; Grandis JR; Johnson DE
Neoplasia; 2007 Oct; 9(10):801-11. PubMed ID: 17971900
[TBL] [Abstract][Full Text] [Related]
8. Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases.
Holinger EP; Chittenden T; Lutz RJ
J Biol Chem; 1999 May; 274(19):13298-304. PubMed ID: 10224090
[TBL] [Abstract][Full Text] [Related]
9. Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing.
Wang K; Gross A; Waksman G; Korsmeyer SJ
Mol Cell Biol; 1998 Oct; 18(10):6083-9. PubMed ID: 9742125
[TBL] [Abstract][Full Text] [Related]
10. After embedding in membranes antiapoptotic Bcl-XL protein binds both Bcl-2 homology region 3 and helix 1 of proapoptotic Bax protein to inhibit apoptotic mitochondrial permeabilization.
Ding J; Mooers BHM; Zhang Z; Kale J; Falcone D; McNichol J; Huang B; Zhang XC; Xing C; Andrews DW; Lin J
J Biol Chem; 2014 Apr; 289(17):11873-11896. PubMed ID: 24616095
[TBL] [Abstract][Full Text] [Related]
11. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
Santiveri CM; Sborgi L; de Alba E
J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics study of peptide segments of the BH3 domain of the proapoptotic proteins Bak, Bax, Bid and Hrk bound to the Bcl-xL and Bcl-2 proteins.
Pinto M; Perez JJ; Rubio-Martinez J
J Comput Aided Mol Des; 2004 Jan; 18(1):13-22. PubMed ID: 15143800
[TBL] [Abstract][Full Text] [Related]
13. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
Simonian PL; Grillot DA; Merino R; Nuñez G
J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
[TBL] [Abstract][Full Text] [Related]
14. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Bax-induced cytochrome c release from neural cell and brain mitochondria by dibucaine and propranolol.
Polster BM; Basañez G; Young M; Suzuki M; Fiskum G
J Neurosci; 2003 Apr; 23(7):2735-43. PubMed ID: 12684459
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the antiapoptotic protein Nr-13 and cytochrome c. Antagonistic effect of the BH3 domain of Bax.
Moradi-Améli M; Lorca T; Ficheux D; di Pietro A; Gillet G
Biochemistry; 2002 Jul; 41(27):8540-50. PubMed ID: 12093270
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells.
Liu Z; Lu H; Jiang Z; Pastuszyn A; Hu CA
Mol Cancer Res; 2005 Jan; 3(1):21-31. PubMed ID: 15671246
[TBL] [Abstract][Full Text] [Related]
18. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
Chu F; Borthakur A; Sun X; Barkinge J; Gudi R; Hawkins S; Prasad KV
Apoptosis; 2004 Jan; 9(1):83-95. PubMed ID: 14739602
[TBL] [Abstract][Full Text] [Related]
19. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
[TBL] [Abstract][Full Text] [Related]
20. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
Raghav PK; Verma YK; Gangenahalli GU
Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
